Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor

Annals of Pharmacotherapy

Volumn 41, Issue 2, 2007, Pages 350-353

  Johnson, Tami N ^a   Canada, Todd W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cushing's syndrome; Ectopic adrenocorticotropic hormone; Etomidate

Indexed keywords

CISPLATIN; CORTICOTROPIN; DEXAMETHASONE; DILTIAZEM; DOXAZOSIN; ETOMIDATE; ETOPOSIDE; FLUCONAZOLE; GLIPIZIDE; HYDROCORTISONE; METYRAPONE; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TORASEMIDE;

ADD ON THERAPY; ADRENAL FUNCTION; AGED; ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETER; CHEMOTHERAPY; CONTINUOUS INFUSION; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG INHIBITION; DRUG MECHANISM; ECTOPIC CORTICOTROPIN PRODUCTION; FEBRILE NEUTROPENIA; HEART ATRIUM FIBRILLATION; HEMODYNAMIC MONITORING; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTENSIVE CARE UNIT; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NASOGASTRIC TUBE; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY FAILURE; SEDATION; SYMPTOM; SYRINGE; URINE LEVEL;

ACTH SYNDROME, ECTOPIC; ADRENOCORTICOTROPIC HORMONE; AGED; CUSHING SYNDROME; ETOMIDATE; FATAL OUTCOME; HUMANS; HYDROCORTISONE; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; MALE; PROSTATIC NEOPLASMS;

EID: 33847388464     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H365     Document Type: Article

References (14)

1. Rickman T, Garmany R, Doherty T, Benson D, Okusa MD. Hypokalemia, metabolic alkalosis, and hypertension: Cushing's syndrome in a patient with metastatic prostate adenocarcinoma. Am J Kidney Dis 2001;37:838-46.
2. Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003;138:980-91.
3. Tash JA, Reuter V, Russo P. Metastatic carcinoid tumor of the prostate. Urology 2002;167:2526-7.
4. Arnold SM, Lieberman FS, Foon KA. Paraneoplastic syndromes. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 7th ed. Philadelphia: Lippincott, Williams & Wilkins, 2000:2189-211.
5. Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005;118:1340-6.
6. Etomidate. In: Lacy CF, Armstrong LL, Goldman MP, Lance LL, eds. Drug information handbook. 13th ed. Hudson: Lexi-Comp, 2005:594.
7. Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984;39:973-81.
8. Jackson WL. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? Chest 2005;127:1031-8.
9. Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 1990;70:1426-30.
10. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984;310:1415-21.
11. Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab 1998;83:3542-4.
12. Allolio B, Stuttmann R, Fischer H, Leonhard W, Winkelman W. Long-term etomidate and adrenocortical suppression. Lancet 1983;1:626.
13. Wanscher M, Tonnesen E, Huttel M, Larsen K. Etomidate infusion and adrenocortical function: a study in elective surgery. Acta Anaesthesiol Scand 1985;29:483-5.
14. Krakoff J, Koch CA, Calis A, Alexander RH, Nieman LK. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab 2001;86:4104-8.